Poland· PL-100099219
Magne-Balans Plus
A magnesium, kombination verschiedener salze product containing magnesii hydrogenoaspartas + kalii hydrogenoaspartas, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o.. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Magnesium, kombination verschiedener salze is registered in 6 of 19 countries.
Countries holding a registration under ATC A12CC30 (magnesium, kombination verschiedener salze), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Magnesium, kombination verschiedener salze · ATC A12CC30
6 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Magnesii hydrogenoaspartas + Kalii hydrogenoaspartas
- Manufacturer
- Aflofarm Farmacja Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A12CC30
- ATC class
- Magnesium, Kombination verschiedener Salze
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990851218
- gtin05909990851225
- gtin05909990851232
- gtin05909990851249
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
13 interactions on record for magnesium, kombination verschiedener salze.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Magnesium, kombination verschiedener salze · interactions on record
13 records
13 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under A12CC30
Magnesium, kombination verschiedener salze, as other registers publish it.
- DenmarkMagnesium "Protina"Protina Pharmazeutische Gesellschaft mbH
- SwitzerlandMagnesium Biomed, FilmtablettenBiomed AG
- SwitzerlandMagnesium Biomed, FilmtablettenBiomed AG
- FinlandMagnesium DiasporalProtina Pharmazeutische Gesellschaft mbH
- SwitzerlandMagnesium Sandoz 243, BrausetablettenSandoz Pharmaceuticals AG
- SwitzerlandMagnesium Sandoz 243, BrausetablettenSandoz Pharmaceuticals AG
- SwitzerlandMagnesium Sandoz 243, BrausetablettenSandoz Pharmaceuticals AG
- SwitzerlandMagnesium Sandoz, BrausetablettenSandoz Pharmaceuticals AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/223bb0a6-5015-449e-bad9-c8ca51a006d7 GET /v1/drugs/223bb0a6-5015-449e-bad9-c8ca51a006d7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "17 mg jonów magnezu + 54 mg jonów potasu",
"packaging": "05909990851218 ¦ OTC ¦ 16994\n50 tabl.\n05909990851225 ¦ OTC ¦ Skasowane ¦ 16995\n50 tabl. w pojemniku\n05909990851232 ¦ OTC ¦ Skasowane ¦ 16996\n50 tabl. w słoiku\n05909990851249 ¦ OTC ¦ Skasowane ¦ 17764\n50 tabl. w blistrach (5 x 10)",
"substance": "Magnesii hydrogenoaspartas 0.25 g + Kalii hydrogenoaspartas 0.25 g",
"common_name": "Magnesii hydrogenoaspartas + Kalii hydrogenoaspartas",
"pl_product_id": "100099219",
"pozwolenie_nr": "08512",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about magnesium, kombination verschiedener salze.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.